About UCSF Search UCSF UCSF Medical Center

Jody Lynn Baron, MD, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
baron_jody

Assistant Professor of Medicine, Department of Medicine (Infectious Diseases and Gastroenterology), UCSF

jody.baron@ucsf.edu

Phone: (415) 476-5728 (appts)
Box 0538, UCSF
San Francisco, CA 94143-0532

View on UCSF Profiles


Education

Swarthmore College, Swarthmore, PA, 1984-85 Rice University, Houston, Texas, BA, 1986, Biology & Philosophy
Yale University, MD 1993, Medicine
Yale University, PhD, 1994, Immunobiology
Stanford University, Residency, 1993-95 Internal Medicine
University of California, San Francisco, Clinical Fellow, 1995-96, Infectious Diseases
University of California, San Francisco, Fellowship, 1996-2000, Microbiol & Immunology
 


Professional Experience

  • 2000- 2002
    Assistant Research Scientist Departments of Microbiology and Immunology, and Internal Medicine, University of California, San Francisco
  • 2003-2
    Assistant Professor of Medicine Department of Medicine, Divisions of Infectious Diseases & Gastroenterology (UCSF Liver Center), University of California, San Francisco

Honors & Awards

  • 1982
    Westinghouse Science Talent Search honors group
  • 1992
    NIH Resident research award
  • 1986-1992
    NIH Fellowship -Medical Scientist Training Program Yale University
  • 1992
    Molecular Medicine Fellowship, University of California at San Francisco
  • 1997-2002
    Howard Hughes Postdoctoral Research Fellowship for Physicians
  • 1992
    UCSF Liver center pilot research grant
  • 2000-2002
    Pfizer Postdoctoral Fellowship in Infectious Diseases
  • 2003-2002
    Burroughs Wellcome Career Award in the Biomedical Sciences
  • 2002
    HHMI/BWF Leadership Coaching Award
  • 2002
    American Gastroenterological Association Fiterman Basic Science Award
  • 2004-2002
    American Liver Foundation Liver Scholar Award
  • 2005-2002
    Cancer Research Institute Investigator award
  • 2006-2011
    Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease
  • 2011-2013
    UCSF Program in Breakthrough Biomedical Research Award

Selected Publications

  1. Minagawa S, Lou J, Seed RI, Cormier A, Wu S, Cheng Y, Murray L, Tsui P, Connor J, Herbst R, Govaerts C, Barker T, Cambier S, Yanagisawa H, Goodsell A, Hashimoto M, Brand OJ, Cheng R, Ma R, McKnelly KJ, Wen W, Hill A, Jablons D, Wolters P, Kitamura H, Araya J, Barczak AJ, Erle DJ, Reichardt LF, Marks JD, Baron JL, Nishimura SL. Selective Targeting of TGF-ß Activation to Treat Fibroinflammatory Airway Disease. Sci Transl Med. 2014 Jun 18; 6(241):241ra79.
    View on PubMed
  2. Fomin ME, Zhou Y, Beyer AI, Publicover J, Baron JL, Muench MO. Production of factor VIII by human liver sinusoidal endothelial cells transplanted in immunodeficient uPA mice. PLoS One. 2013; 8(10):e77255.
    View on PubMed
  3. Publicover J, Gaggar A, Nishimura S, Van Horn CM, Goodsell A, Muench MO, Reinhardt RL, van Rooijen N, Wakil AE, Peters M, Cyster JG, Erle DJ, Rosenthal P, Cooper S, Baron JL. Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest. 2013 Sep 3; 123(9):3728-39.
    View on PubMed
  4. Zeissig S, Murata K, Sweet L, Publicover J, Hu Z, Kaser A, Bosse E, Iqbal J, Hussain MM, Balschun K, Röcken C, Arlt A, Günther R, Hampe J, Schreiber S, Baron JL, Moody DB, Liang TJ, Blumberg RS. Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity. Nat Med. 2012 Jul; 18(7):1060-8.
    View on PubMed
  5. Kitamura H, Cambier S, Somanath S, Barker T, Minagawa S, Markovics J, Goodsell A, Publicover J, Reichardt L, Jablons D, Wolters P, Hill A, Marks JD, Lou J, Pittet JF, Gauldie J, Baron JL, Nishimura SL. Mouse and human lung fibroblasts regulate dendritic cell trafficking, airway inflammation, and fibrosis through integrin avß8-mediated activation of TGF-ß. J Clin Invest. 2011 Jul; 121(7):2863-75.
    View on PubMed
  6. Publicover J, Goodsell A, Nishimura S, Vilarinho S, Wang ZE, Avanesyan L, Spolski R, Leonard WJ, Cooper S, Baron JL. IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest. 2011 Mar; 121(3):1154-62.
    View on PubMed
  7. Vilarinho S, Ogasawara K, Nishimura S, Lanier LL, Baron JL. Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus. Proc Natl Acad Sci U S A. 2007 Nov 13; 104(46):18187-92.
    View on PubMed
  8. Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L, Kronenberg M, Locksley RM. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med. 2003 Oct 6; 198(7):1069-76.
    View on PubMed
  9. Matsuda JL, Gapin L, Baron JL, Sidobre S, Stetson DB, Mohrs M, Locksley RM, Kronenberg M. Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo. Proc Natl Acad Sci U S A. 2003 Jul 8; 100(14):8395-400.
    View on PubMed
  10. Mu D, Cambier S, Fjellbirkeland L, Baron JL, Munger JS, Kawakatsu H, Sheppard D, Broaddus VC, Nishimura SL. The integrin alpha(v)beta8 mediates epithelial homeostasis through MT1-MMP-dependent activation of TGF-beta1. J Cell Biol. 2002 Apr 29; 157(3):493-507.
    View on PubMed
  11. Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity. 2002 Apr; 16(4):583-94.
    View on PubMed
  12. Cerwenka A, Baron JL, Lanier LL. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc Natl Acad Sci U S A. 2001 Sep 25; 98(20):11521-6.
    View on PubMed

Go to UCSF Profiles, powered by CTSI